This spectrum of actions suggests that decreased humanin production may be related to the pathophysiology of uremia characterized by insulin insensitivity, activated inflammatory processes, increased oxidative stress, impaired endothelial function, and premature atherosclerosis. The gene discussed is INS; the disease is uremia.